nificant predictor of unfavorable prognosis (HR 2.67, 95% CI 1.03-7.76, p = 0.044). Conclusions: Surgical resection, regardless of status of surgical resection margin, contributed to a favorable prognosis in adult patients with locally advanced or metastatic urological STS.
variate analysis. In the present study, a series of 25 adult urological STS at our institution were reviewed and their prognostic factors were analyzed. This is the largest such series reported to date in Japan.
Patients and Methods

Patients
Patients histologically diagnosed as having STS arising in organs treated by urologists, such as the urinary tract, male genital system, or retroperitoneum, from January 1983 to July 2008 were included in this study. All patients were 15 years or older at diagnosis. Variables analyzed were patient age, sex, tumor size, and histological subtype, primary organ, metastasis at diagnosis, and status of the surgical resection margins. Postoperative adjuvant therapies and treatment after recurrences were also described. Although 2 patients were operated with palliative intent to improve local symptoms, we basically intended to resect tumors completely with curative intent at operation. However, as a result, complete resection was not accomplished in all cases. Surgical resection margins were documented by both the surgeon and the pathologist in evaluating resected specimens. In accordance with the National Comprehensive Cancer Network [4] , the status of surgical resection margins was defined as follows: R0 resection, no residual microscopic disease; R1 resection, microscopic residual disease; R2 resection, gross residual disease. Local recurrence or metastasis was defined as the first recurrence of disease at the primary tumor site or distant site detected by radiographic modality, such as computed tomography.
Statistical Analysis
The date of surgery or biopsy was used as the start of observation. Overall survival was the study endpoint. The crude probability of survival was estimated using the Kaplan-Meier method. Univariate analysis of differences between patient groups was performed with the log rank test. Multivariate analysis of variables that were significant on univariate analysis was analyzed with the Cox proportional hazards model. Statistical significance was defined as p ! 0.05.
Results
Patient Characteristics
Patient characteristics are shown in table 1 . A total of 25 cases were included in this analysis. The most common site was the retroperitoneum (14 cases, 56%), followed by bladder, kidney, and paratesticular tumors each with 3 cases (12%) and the prostate with 2 cases (8%). The most common histological subtype was rhabdomyosarcoma (7 cases, 28%), followed by liposarcoma with 5 cases (20%), malignant fibrous histiocytoma and leiomyosarcoma each with 4 cases (16%). The remaining 5 cases had other histological subtypes (20%), which included angiosarcoma, malignant hemangiopericytoma, malignant schwannoma, malignant solitary fibrous tumor, and unclassified sarcoma. Of the 25 patients, 5 (20%) presented with metastatic disease and 21 (84%) underwent surgical resection. Of these 21 patients, 19 (90%) underwent surgical resection with curative intent and 2 (10%) underwent surgical resection with palliative intent (R2 resection). Of the 19 patients who underwent surgical resection with curative intent, 8 (42%) underwent complete resection (R0 resection), 6 (32%) underwent incomplete resection with microscopically residual disease (R1 resection) and 2 (11%) underwent incomplete resection with gross residual disease (R2 resection). Surgical resection margin status was not determined in 3 patients (16%) (Rx resection). All 11 patients of R0 and Rx resection did not undergo postoperative adjuvant therapy. Four of 8 R0 resection patients had recurrence and 3 patients underwent treatment after recurrence as follows: reoperation of tumor resection, chemotherapy (CT), embolization followed by radiofrequency ablation. All 3 Rx patients had recurrence and underwent treatment after recurrence as follows; radiation therapy (RT), CT with RT (2 patients). Two of 6 R1 resection patients underwent postoperative adjuvant therapy of CT and CT with RT. Five of 6 R1 resection patients, including 2 patients who underwent postoperative adjuvant therapy, had recurrence and underwent treatment after recurrence as follows: CT with RT, immunotherapy, reoperation of tumor resection (2 patients), reoperation of tumor resection followed by CT. One of 4 R2 resection patients underwent CT with RT after surgical resection. The median (range) recurrence interval of R0, R1 and Rx resection was 41.5 (14-69), 4 (2-53) and 41 (7-77) months, respectively. Two R0 resection patients had distant recurrence sites, one had multiple bone metastases and the other had liver and thighbone metastases. Other patients had local recurrences. Four of 10 local recurrence patients underwent reoperation with curative intent and the number of R0, R1 and Rx patients was 2, 1 and 1, respectively. All of the 4 patients who did not undergo surgical resection underwent CT, RT (2 patients), and CT with RT.
Overall Survival
At the end of the follow-up period, 15 of the 25 patients were alive. Overall survival rate at 5 years was 54.2% and median survival time was 63 months ( fig. 1 a) . Overall survival rate of inoperable, R2 resection, and recurrent cases at 5 years was 28.1% and median survival time was 25 months ( fig. 1 b) . The distribution of 25 STS according to histological characteristics is shown in table 2 . On uni- fig. 1 c-f ). There were no significant differences in survival according to age (p = 0.1687), sex (p = 0.1722), tumor size (largest dimension classified by ! 10 vs. 1 10, ! 15 vs. 1 15, and ! 20 vs. 1 20 cm; p = 0.1464, 0.4503, and 0.5958, respectively). There were also no significant differences between R0 and R1 resection (p = 0.2385), or between R0 and R1+R2 resection (p = 0.0722). There were no significant differences in survival according to whether undergoing CT or not (p = 0.7084) and undergoing RT or not (p = 0.3721). On multivariate analysis, absence of surgical resection remained a significant predictor of unfavorable prognosis (HR = 2.67, 95% CI = 1.03-7.76, p = 0.044) ( table 3 ).
Discussion
As adult urological STS is very rare, clinical research regarding this disease is difficult. To our knowledge, this is the first case series study of adult urological STS performed in Japan. There have been three previous clinical studies of adult urological STS. Mondaini et al. [5] reported a series including 22 adult patients with genitourinary sarcomas of different histological types who were identified and reviewed in a multicenter study performed in eight different hospitals in Tuscany, Central Italy. The MSKCC group reported two consecutive series, one including 43 patients treated between 1982 and 1989 [6] and another including 131 patients treated between 1977 and 2003. The latter study extended the former with prolonged follow-up and allowed the use of multiple variables for determining local recurrence-free and diseasespecific survival [3] . Less than 5% of STS arise in the genitourinary tract and only 15% of STS arise within the retroperitoneum [2, 7] . All retroperitoneal STS are considered deep lesions with a generally poor prognosis [8, 9] .
Overall survival rate at 5 years was 54.2% and median survival time was 63 months. These results were consistent with those of the previous study by Coindre et al. [10] in which the 5-year survival rate of STS was 50-60%. On univariate analysis, the presence of metastasis, rhabdomyosarcoma, primary organs other than the retroperitoneum, and absence of surgical resection were unfavorable prognostic variables for overall survival. The presence of metastasis and rhabdomyosarcoma were reported previously to be unfavorable prognostic variables [3] . The prognosis of genitourinary STS may be more unfavorable than that of retroperitoneal STS. On multivariate analy- Total  25  5  21  14  3  3 sis, the absence of surgical resection remained as an unfavorable prognostic variable for overall survival. Lewis et al. [11] reported the presence of unresectable disease and incomplete surgical resection as the most significant factors predictive of disease-specific death. In a study by van Dalen et al. [12] in 143 patients treated in the Netherlands, complete tumor resection was correlated with better overall survival on multivariate analysis. However, Dotan et al. [3] reported that complete resection was not a significant factor predictive of disease-specific survival on uni-and multivariate analysis in 102 patients with primary tumors only. Interestingly, in the present study there were no significant differences between R0 and R1 resection or between R0 and R1+R2 resection. These results suggest that any type of surgical resection can provide the best chance of survival in patients presenting with primary disease or with primary and metastatic disease. Size of STS is an important prognostic variable. According to the American Joint Committee on Cancer staging criteria for STS, sarcomas have classically been stratified into two groups on the basis of size: T1 lesions are ^ 5 cm and T2 lesions are 1 5 cm [13] . In the present study, all sarcomas were 1 5 cm in the largest dimension. This may have been because STS arising from retroperitoneum can achieve a large size due to the flexibility of the retroperitoneum and the large volume of space available for organ displacement. There were no significant differences in size of tumors in the present study. However, Ramanathan et al. [14] suggested that further stratification of tumors 1 5 cm would provide more accurate prognostic information. When 316 patients with STS were grouped into four subgroups on the basis of tumor size ( ! 5, 5 to ! 10 cm, 10-15, and 1 15 cm), each subgroup had a different prognosis, as shown by the 5-year survival rates of 84, 70, 50, and 33%, respectively. R0 resection may be an important prognostic factor in the early phase of STS with small tumors ! 5 cm. However, any type of surgical resection can be a prognostic factor in the advanced phase with large tumors 1 5 cm or with metastases as in the present cases.
As to metastatic or advanced STS except for specific types of sarcomas such as gastrointestinal stromal tumor, the effect of CT or RT is not established. In the present study, R1 and R2 resection patients could be comparable with R0 resection patients in respect to postoperative adjuvant therapy, because only 2 R1 resection patients underwent postoperative adjuvant therapy of CT or CT with RT. It may be improper to assess the efficacy of CT and RT, because the sample size was small and various treatments were metachronously performed. However, we tried to analyze the efficacy of CT and RT on univariate analysis about inoperable, R2 resection, and recurrent cases. We could not clarify that surgical resection improved the efficacy of CT and RT.
The present study had a number of limitations. Small sample size may have prevented determination of the precise statistical significance. Histological grade was not considered as a prognostic variable in the present study because it was not clear in some older specimens. Moreover, all patients were Japanese, so the distribution of STS according to histological subtype or primary organ may differ in patients from other ethnic backgrounds.
Finally, this study provided evidence that surgical resection, regardless of the status of the surgical margins, may contribute to a favorable prognosis in adult patients with urological STS. Larger prospective studies with longer follow-up periods are needed to confirm these findings.
Conclusion
In the present study, although sample size was small, it was confirmed that surgical resection, regardless of status of surgical margins, may contribute to a favorable prognosis in adult patients with locally advanced or metastatic urological STS.
